D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 71 Citations 37,690 268 World Ranking 14943 National Ranking 7784

Research.com Recognitions

Awards & Achievements

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Diabetes mellitus
  • Disease

Chi-yuan Hsu mostly deals with Internal medicine, Kidney disease, Renal function, Surgery and Creatinine. Chi-yuan Hsu frequently studies issues relating to Endocrinology and Internal medicine. His study in Kidney disease is interdisciplinary in nature, drawing from both Epidemiology, Cohort study, Intensive care medicine, End stage renal disease and Risk factor.

His study on Renal function also encompasses disciplines like

  • Diabetes mellitus, which have a strong connection to Disease,

  • Hazard ratio and related Apolipoprotein L1. His Surgery research incorporates elements of Body mass index, Hemodynamics, Quality of life and National Health and Nutrition Examination Survey. His Creatinine study also includes

  • Cohort that intertwine with fields like Cystatin C,

  • Renal physiology and related Hematocrit.

His most cited work include:

  • CHRONIC KIDNEY DISEASE AND THE RISKS OF DEATH, CARDIOVASCULAR EVENTS, AND HOSPITALIZATION (8383 citations)
  • Body Mass Index and Risk for End-Stage Renal Disease (966 citations)
  • Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease (786 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Internal medicine, Kidney disease, Renal function, Cohort and Creatinine. The study incorporates disciplines such as Diabetes mellitus and Endocrinology in addition to Internal medicine. His work carried out in the field of Kidney disease brings together such families of science as Nephrology, Cohort study, Intensive care medicine, Acute kidney injury and Risk factor.

His biological study spans a wide range of topics, including Cardiology, Proteinuria, Kidney and Urology. His studies in Cohort integrate themes in fields like Interquartile range and Retrospective cohort study. His Dialysis study incorporates themes from Logistic regression and Hemodialysis.

He most often published in these fields:

  • Internal medicine (95.52%)
  • Kidney disease (85.17%)
  • Renal function (67.59%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (95.52%)
  • Kidney disease (85.17%)
  • Renal function (67.59%)

In recent papers he was focusing on the following fields of study:

Chi-yuan Hsu mainly investigates Internal medicine, Kidney disease, Renal function, Cohort and Acute kidney injury. His study in Internal medicine focuses on Prospective cohort study, Dialysis, Cohort study, Risk factor and Heart failure. His work focuses on many connections between Risk factor and other disciplines, such as Lower risk, that overlap with his field of interest in Body mass index.

He has included themes like Nephrology, Gastroenterology, Proportional hazards model, Hazard ratio and Kidney in his Kidney disease study. His work deals with themes such as Creatinine, Proteinuria, Diabetes mellitus and Urology, which intersect with Renal function. The Cohort study combines topics in areas such as Interquartile range, Disease, Retrospective cohort study and Confidence interval.

Between 2018 and 2021, his most popular works were:

  • Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression (29 citations)
  • Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study. (25 citations)
  • Post-Acute Kidney Injury Proteinuria and Subsequent Kidney Disease Progression: The Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Study. (20 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Diabetes mellitus
  • Disease

The scientist’s investigation covers issues in Kidney disease, Internal medicine, Renal function, Prospective cohort study and Risk factor. His Kidney disease research is multidisciplinary, relying on both Inflammation, Gastroenterology, Blood pressure and Transplantation. Internal medicine and Diabetes mellitus are frequently intertwined in his study.

His Renal function research integrates issues from Urology, Proteinuria, Kidney, Hazard ratio and Creatinine. His Hazard ratio research focuses on subjects like End stage renal disease, which are linked to Stroke and Myocardial infarction. His study looks at the relationship between Risk factor and fields such as Interquartile range, as well as how they intersect with chemical problems.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

CHRONIC KIDNEY DISEASE AND THE RISKS OF DEATH, CARDIOVASCULAR EVENTS, AND HOSPITALIZATION

A.S. Go;G.M. Chertow;D. Fan;C.E. McCulloch.
The New England Journal of Medicine (2004)

11906 Citations

Body Mass Index and Risk for End-Stage Renal Disease

Chi-yuan Hsu;Charles E. McCulloch;Carlos Iribarren;Jeanne Darbinian.
Annals of Internal Medicine (2006)

1373 Citations

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

Tamara Isakova;Patricia Wahl;Gabriela S. Vargas;Orlando M. Gutiérrez.
Kidney International (2011)

1039 Citations

Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients with Chronic Kidney Disease

Tamara Isakova;Huiliang Xie;Wei Yang;Dawei Xie.
JAMA (2011)

958 Citations

Renal Insufficiency in the Absence of Albuminuria and Retinopathy Among Adults With Type 2 Diabetes Mellitus

Holly J. Kramer;Quan Dong Nguyen;Gary Curhan;Chi Yuan Hsu.
JAMA (2003)

694 Citations

Epidemiology of Anemia Associated with Chronic Renal Insufficiency among Adults in the United States: Results from the Third National Health and Nutrition Examination Survey

Chi-yuan Hsu;Charles E. McCulloch;Gary C. Curhan.
Journal of The American Society of Nephrology (2002)

640 Citations

Community-based incidence of acute renal failure

C.-y. Hsu;C.E. McCulloch;D. Fan;J.D. Ordoñez.
Kidney International (2007)

607 Citations

Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease.

Lowell J. Lo;Alan S. Go;Alan S. Go;Glenn M. Chertow;Charles E. McCulloch.
Kidney International (2009)

569 Citations

Risk factors for end-stage renal disease: 25-year follow-up.

Chi-yuan Hsu;Carlos Iribarren;Charles E. McCulloch;Jeanne Darbinian.
JAMA Internal Medicine (2009)

567 Citations

APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease

Afshin Parsa;W. H Linda Kao;Dawei Xie;Brad C. Astor.
The New England Journal of Medicine (2013)

557 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Chi-yuan Hsu

Michael G. Shlipak

Michael G. Shlipak

University of California, San Francisco

Publications: 265

Csaba P. Kovesdy

Csaba P. Kovesdy

University of Tennessee Health Science Center

Publications: 181

Josef Coresh

Josef Coresh

Johns Hopkins University

Publications: 157

Joachim H. Ix

Joachim H. Ix

University of California, San Diego

Publications: 156

Kamyar Kalantar-Zadeh

Kamyar Kalantar-Zadeh

University of California, Irvine

Publications: 148

Andrew S. Levey

Andrew S. Levey

Tufts Medical Center

Publications: 136

Alan S. Go

Alan S. Go

Kaiser Permanente

Publications: 133

Raymond R. Townsend

Raymond R. Townsend

University of Pennsylvania

Publications: 133

Myles Wolf

Myles Wolf

Duke University

Publications: 133

Mark J. Sarnak

Mark J. Sarnak

Tufts Medical Center

Publications: 124

Glenn M. Chertow

Glenn M. Chertow

Stanford University

Publications: 122

Harold I. Feldman

Harold I. Feldman

University of Pennsylvania

Publications: 121

Chirag R. Parikh

Chirag R. Parikh

Johns Hopkins University

Publications: 113

Amit X. Garg

Amit X. Garg

University of Western Ontario

Publications: 104

Lawrence J. Appel

Lawrence J. Appel

Johns Hopkins University

Publications: 98

Carmen A. Peralta

Carmen A. Peralta

University of California, San Francisco

Publications: 95

Trending Scientists

Erik Winfree

Erik Winfree

California Institute of Technology

Yuri Gurevich

Yuri Gurevich

Microsoft (United States)

Robert E. Schapire

Robert E. Schapire

Microsoft (United States)

Wing Thye Woo

Wing Thye Woo

University of California, Davis

Narendra N. Bakhshi

Narendra N. Bakhshi

University of Saskatchewan

Sheena E. Radford

Sheena E. Radford

University of Leeds

Huaping Xu

Huaping Xu

Tsinghua University

Jialong Zhao

Jialong Zhao

Guangxi University

Christopher Turbill

Christopher Turbill

University of Sydney

Carl W. Hunt

Carl W. Hunt

University of Idaho

Giuseppe Piccione

Giuseppe Piccione

University of Messina

Roshni R. Singaraja

Roshni R. Singaraja

Agency for Science, Technology and Research

Thomas E. Roche

Thomas E. Roche

Kansas State University

Frederick T. L. Leong

Frederick T. L. Leong

Michigan State University

Ammar Al-Chalabi

Ammar Al-Chalabi

King's College London

Something went wrong. Please try again later.